Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 59.00
+8.10 (15.91%)
At close: Jun 12, 2026
Nextage Therapeutics Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 0.17 | - | 0.4 | 1.05 | - | 2.03 |
Short-Term Investments | - | 0.25 | 0.08 | 0.08 | - | 0.04 |
Cash & Short-Term Investments | 0.17 | 0.25 | 0.48 | 1.13 | - | 2.07 |
Cash Growth | 34.68% | -47.18% | -57.57% | - | - | - |
Accounts Receivable | 0.76 | 0.05 | 0.25 | 0.01 | - | - |
Other Receivables | 0.45 | 0.02 | 0.14 | 0.18 | - | 0.44 |
Receivables | 1.22 | 0.06 | 0.4 | 0.2 | - | 0.44 |
Prepaid Expenses | 0.02 | - | - | 0.1 | - | 0.01 |
Other Current Assets | 0.04 | 0 | 0.01 | - | - | - |
Total Current Assets | 1.44 | 0.32 | 0.89 | 1.42 | - | 2.51 |
Property, Plant & Equipment | 1.73 | 0.04 | 0.21 | 0.09 | - | 0.24 |
Other Intangible Assets | - | - | - | - | - | 1.32 |
Total Assets | 46.84 | 0.35 | 1.1 | 1.51 | - | 4.07 |
Accounts Payable | 2.6 | 0.24 | 0.12 | 0.14 | - | 0.21 |
Accrued Expenses | 10.73 | 5.4 | 3.29 | 1.43 | - | 1.03 |
Short-Term Debt | 0.21 | 0.03 | - | - | - | - |
Current Portion of Long-Term Debt | 8.11 | 0.14 | 0.23 | 0.21 | - | 0.26 |
Current Portion of Leases | 1.03 | 0.05 | 0.08 | - | - | - |
Total Current Liabilities | 22.91 | 5.85 | 3.73 | 1.77 | - | 1.5 |
Long-Term Debt | 3 | - | - | 0.12 | - | 0.58 |
Long-Term Leases | 0.26 | - | 0.07 | - | - | - |
Other Long-Term Liabilities | 0.32 | 0.04 | 0.04 | 0.04 | - | 0.54 |
Total Liabilities | 26.48 | 5.89 | 3.83 | 1.94 | - | 2.62 |
Common Stock | - | - | 60.54 | 56.06 | - | 50.76 |
Additional Paid-In Capital | 87.33 | 63.15 | 1.43 | 4.53 | - | 2.71 |
Retained Earnings | -66.65 | -42.54 | -39.26 | -35.38 | - | -22.06 |
Comprehensive Income & Other | - | -26.13 | -25.61 | -26.11 | - | -29.96 |
Total Common Equity | 20.68 | -5.52 | -2.9 | -0.9 | - | 1.45 |
Minority Interest | -0.32 | -0.02 | 0.16 | 0.47 | - | - |
Shareholders' Equity | 20.36 | -5.54 | -2.74 | -0.43 | - | 1.45 |
Total Liabilities & Equity | 46.84 | 0.35 | 1.1 | 1.51 | - | 4.07 |
Total Debt | 12.61 | 0.21 | 0.38 | 0.33 | - | 0.84 |
Net Cash (Debt) | -12.44 | 0.04 | 0.1 | 0.8 | - | 1.23 |
Net Cash Growth | - | -57.43% | -87.30% | - | - | - |
Net Cash Per Share | -0.70 | 0.00 | 0.00 | 0.03 | - | 0.11 |
Filing Date Shares Outstanding | 22.6 | 33.7 | 30.27 | 27.85 | 26.03 | 11.43 |
Total Common Shares Outstanding | 22.6 | 33.7 | 30.27 | 27.85 | 26.03 | 11.43 |
Working Capital | -21.46 | -5.54 | -2.84 | -0.35 | - | 1.01 |
Book Value Per Share | 0.92 | -0.16 | -0.10 | -0.03 | - | 0.13 |
Tangible Book Value | 20.68 | -5.52 | -2.9 | -0.9 | - | 0.13 |
Tangible Book Value Per Share | 0.92 | -0.16 | -0.10 | -0.03 | - | 0.01 |
Machinery | - | 0.19 | 0.19 | 0.19 | - | - |